Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Schizophrenia Clinical Trials

110 recruiting trials for Schizophrenia. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
110
Total Trials
110
Recruiting Now
10
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGPhase 1NCT07230652

A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

This is a randomized, double-blind, placebo-controlled, ascending multiple oral dose study to assess the safety, tolerability, and pharmacokinetics of LY03020 in Chinese healthy...

Sponsor: Luye Pharma Group Ltd.Enrolling: 401 location
RECRUITINGNCT06904079

Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal...

Mental health issues represent a major public health and social problem that significantly impacts economic and social development. Compared to other diseases, mental disorders...

Sponsor: Shanghai Mental Health CenterEnrolling: 821 location
RECRUITINGNCT04610697

Cognitive Remediation in Forensic Mental Health Care

Forensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. One...

Sponsor: The Royal Ottawa Mental Health CentreEnrolling: 301 location
RECRUITINGNCT06890208

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

The CLIMATE-III Observational Study examines to what extent chronically ill patients experience adverse health effects because of heat and whether the patients' specific health...

Sponsor: Universitätsklinikum Hamburg-EppendorfEnrolling: 2401 location
RECRUITINGNCT05698589

COMpassion for Psychiatric Disorders And Self-Stigma

People with mental disorders face frequent stigmatizing attitudes and behaviors from others . In response to this, they tend to isolate themselves, with the risk of impeding care...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 3367 locations
RECRUITINGPhase 1NCT05025605

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

This is a study of the efficacy and safety of BXCL501 in children and adolescents with acute agitation and either bipolar disorder or schizophrenia.

Sponsor: BioXcel Therapeutics IncEnrolling: 1405 locations
RECRUITINGPhase 3NCT06229210

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism...

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar disorder or autism...

Sponsor: Intra-Cellular Therapies, Inc.Enrolling: 50020 locations
RECRUITINGNCT03601026

Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use

Severe mental illness (SMI) refers to the most burdensome psychiatric conditions. The need to pre-empt the onset of SMI is pressing because once SMI develops, quality of life is...

Sponsor: Nova Scotia Health AuthorityEnrolling: 1201 location
RECRUITINGPhase 4NCT07105111

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain...

This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.

Sponsor: Neurocrine BiosciencesEnrolling: 508 locations
RECRUITINGNCT05491538

Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

Many individuals with serious mental illness have difficulty accurately interpreting interpersonal cues and effectively engaging in social exchanges. Difficulties related to the...

Sponsor: VA Office of Research and DevelopmentEnrolling: 201 location
RECRUITINGNCT01980147

Skills for Wellness

Severe mental illness such as schizophrenia and mood disorders typically develops at a young age and can cause life-long disability. Currently available treatments cannot cure...

Sponsor: Nova Scotia Health AuthorityEnrolling: 3602 locations
RECRUITINGNCT04946916

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

The validation of biomarkers allowing the discrimination of cognitive and behavioral disorders of psychiatric origin from those of neurodegenerative origin would facilitate...

Sponsor: Hôpital le VinatierEnrolling: 1202 locations
RECRUITINGNCT04432116

Time and Virtual Reality in Schizophrenia and Bipolar Disorder

Patients with bipolar disorders report an acceleration or slowing of time flow, and patients with schizophrenic spectrum disorders a time fragmentation. These disorders would be...

Sponsor: Institut National de la Santé Et de la Recherche Médicale, FranceEnrolling: 1201 location
RECRUITINGNCT06700902

Taking Action for College Students

The goal of this research is to investigate whether a peer-delivered illness self-management program called Taking Action can help college students with serious mental illnesses....

Sponsor: Temple UniversityEnrolling: 3001 location
RECRUITINGNCT06740383

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia,...

Sponsor: Beth Israel Deaconess Medical CenterEnrolling: 3206 locations
RECRUITINGNCT03217110

Cerebellar Stimulation and Cognitive Control

The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder,...

Sponsor: Krystal Parker, PhDEnrolling: 2001 location
RECRUITINGPhase 4NCT05648591

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.

Sponsor: Vanda PharmaceuticalsEnrolling: 1009 locations
RECRUITINGPhase 3NCT05303064

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar...

To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine

Sponsor: Alkermes, Inc.Enrolling: 22020 locations
RECRUITINGNCT05866107

App and Body Fat Scale in the Management of Overweight Patients

This study tests whether using a health app (Huawei Health) and a smart body fat scale can help overweight patients with schizophrenia or bipolar disorder lose weight and stay...

Sponsor: Capital Medical UniversityEnrolling: 2041 location
RECRUITINGNCT07177261

Inter-Brain Synchrony in Schizophrenia

The goal of this clinical trial is to investigate for the first time in people with schizophrenia a neural mechanism that is thought to facilitate the formation of social...

Sponsor: University of California, Los AngelesEnrolling: 1001 location
RECRUITINGNCT05435300

Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia

This study will examine changes in synaptic density with transcranial direct current stimulation (tDCS) in the brains of patients with schizophrenia. Synaptic density levels will...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 201 location
RECRUITINGNCT06835556

Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy

The goal of this clinical trial is to learn whether learning and belief updating change in response to the treatment of persecutory delusions, in individuals with...

Sponsor: Vanderbilt University Medical CenterEnrolling: 1201 location
RECRUITINGNCT07098169

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

The purpose of this study is to evaluate the effectiveness of a psychosocial intervention called iTEST for people with psychotic disorders that targets introspective accuracy, or...

Sponsor: University of California, San DiegoEnrolling: 2013 locations
RECRUITINGNCT04945278

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability

The main objective of this study is to establish whether there are differences in self-recognition and self/other distinction in subjects with psychological vulnerability compared...

Sponsor: University Hospital, BrestEnrolling: 341 location
RECRUITINGNCT06286202

Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive...

Adults with serious mental illnesses (such as schizophrenia and schizoaffective disorders) often experience a range of cognitive difficulties (such as memory, problem solving...

Sponsor: Singapore Institute of TechnologyEnrolling: 1605 locations
RECRUITINGPhase 2 / Phase 3NCT06191965

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

The goal of this double-blind, placebo-controlled randomized clinical trial is to test the effect of 12 weeks of orally administered MitoQ (mitoquinol mesylate) supplementation on...

Sponsor: Mclean HospitalEnrolling: 1003 locations
RECRUITINGNCT06802939

RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography

This study is an before-after study in the same patient, which enrolled 36 psychiatric patients with refractory auditory hallucinations. The target of patient intervention relies...

Sponsor: Shanghai Mental Health CenterEnrolling: 361 location
RECRUITINGNCT06568081

SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study

Worries about harm from others (also known as paranoia) are common. Thinking fast or going on gut feelings is natural but can fuel these worries. For some, fast thinking and...

Sponsor: King's College LondonEnrolling: 1501 location
RECRUITINGNCT04033679

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

This study seeks to explore the effects of transcranial direct current stimulation (tDCS), a non-invasive method of brain stimulation, as an adjunctive treatment to improve...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 1061 location
RECRUITINGNCT07434479

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

The study investigates whether a virtual reality-based mindfulness based intervention can reduce impulsive aggression in individuals with schizophrenia or schizoaffective...

Sponsor: Manhattan Psychiatric CenterEnrolling: 582 locations
RECRUITINGNCT03332966

Youth Experiences and Health Study

This study aims to identify unusual experiences and psychiatric symptoms that indicate a heightened risk for severe mental disorders - especially psychoses. It is important to...

Sponsor: Finnish Institute for Health and WelfareEnrolling: 10003 locations
RECRUITINGNCT04452175

Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia

Smokers with schizophrenia spectrum disorders have high rates of morbidity and mortality from smoking-related diseases compared with the general population and current options for...

Sponsor: University of CataniaEnrolling: 2601 location
RECRUITINGNCT06224530

Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in...

Background Psychosis is a mental health condition that affects around 3 in 100 people in their lifetime. Most treatments for psychosis target a brain chemical called dopamine but...

Sponsor: King's College LondonEnrolling: 691 location
RECRUITINGNCT06749444

Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia

Using a randomized controlled design, the project aims to test if cognitive behavioral therapy interventions specifically targeting sleep disorders can significantly lessen the...

Sponsor: Jimmi NielsenEnrolling: 601 location
RECRUITINGPhase 3NCT07225712

A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia

To evaluate the safety of SEP-363856 (75 mg/day or 100 mg/day) administered for 52 weeks in adult participants with schizophrenia

Sponsor: Otsuka Pharmaceutical Co., Ltd.Enrolling: 1001 location
RECRUITINGPhase 3NCT05669742

Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients

Olanzapine is a thieno-benzodiazepine derivate that is effective managing the symptoms of schizophrenia and reducing the psychopathological symptoms of psychosis. It is also...

Sponsor: Tanta UniversityEnrolling: 401 location
RECRUITINGNCT06482918

Cognitive Remediation in Schizophrenia: Efficacy and Role of Neuroplasticity in "Top-down" and "Bottom-up" Mechanisms

Schizophrenia patients have deficits of different degrees in several cognitive domains, impacting their social functioning and quality of life. Cognitive remediation strategies...

Sponsor: University of ChileEnrolling: 1601 location
RECRUITINGNCT05580211

Neuromodulation for Schizophrenia

Our proposed study employs a novel approach to determine the clinical and functional imaging effects of brainstem neuromodulation, with an investigational study device, on illness...

Sponsor: Scion NeuroStimEnrolling: 341 location
RECRUITINGNCT05934474

Biocollection on Peripheral Inflammation

Most psychiatric research is based on the nosographic classifications used in current practice. At present, there is no diagnostic or prognostic biomarker for psychiatric...

Sponsor: Nantes University HospitalEnrolling: 3001 location
RECRUITINGNCT06155682

TMS for Inhibition Enhancement in Schizophrenia

This study purpose is to perform a pilot mechanistic trial repetitive transcranial magnetic stimulation (rTMS) clinical trial in 34 people with schizophrenia (Sz). The trial will...

Sponsor: University of Maryland, BaltimoreEnrolling: 341 location
RECRUITINGPhase 4NCT05208190

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site...

Sponsor: New York State Psychiatric InstituteEnrolling: 2807 locations
RECRUITINGPhase 3NCT06961968

Randomized Withdrawal Study in Patients With Schizophrenia

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in...

Sponsor: Vanda PharmaceuticalsEnrolling: 40020 locations
RECRUITINGNCT05617898

Determining the Role of Social Reward Learning in Social Anhedonia

This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and...

Sponsor: University of Alabama at BirminghamEnrolling: 1522 locations
RECRUITINGNCT06508450

A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults

Researchers aim to test a brief culturally-responsive young adult orientation program for community mental health services. They will conduct a 24-month randomized trial with 80...

Sponsor: New York UniversityEnrolling: 801 location
RECRUITINGNCT06945055

FAmily Engagement Strategy for Coordinated Specialty Care

Family members/support persons' engagement in mental health services has been linked to reduced burden and stress and improves engagement and outcomes in individuals in the early...

Sponsor: Washington State UniversityEnrolling: 9004 locations
RECRUITINGNCT05142735

Effects of NAC on Symptoms of CHR Patients

Schizophrenia is a chronic debilitating psychotic disorder. Identifying persons with "clinical high-risk" (CHR) symptoms, which are like those of schizophrenia but less severe,...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 901 location
RECRUITINGNCT05890183

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

The participants in the study will receive psychiatric treatment at the UCLA Aftercare Research Program. All participants in this 12-month RCT will receive cognitive training....

Sponsor: University of California, Los AngelesEnrolling: 1001 location
RECRUITINGNCT06257056

Deep Brain Stimulation for Psychosis

There are three hypotheses proposed for this study: 1) Participants will report no unanticipated serious adverse events during the eight months of treatment. 2) Investigators will...

Sponsor: Bradley LegaEnrolling: 101 location
RECRUITINGPhase 3NCT06882785

A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia

The purpose of this study is to evaluate the efficacy and safety of KarXT in acutely psychotic Japanese adult participants with schizophrenia

Sponsor: Bristol-Myers SquibbEnrolling: 25020 locations

Showing 50 of 110 trials.Search all Schizophrenia trials